Since its approval, there have been no cases of torsades de pointes or unexplained sudden death among US patients treated with Caprelsa.

HealthDay News — During August 2021 to August 2023, only 36.4% of US adults had no cardiovascular disease (CVD) risk factors, according to a September data brief published by the National Center for ...

Up to 32% lower risk conferred by early initiation, while increased risk for dementia seen in studies among older women.

HealthDay News — Cocoa extract supplementation yields a significant reduction in high-sensitivity C-reactive protein (hsCRP) and an increase in interferon-γ (IFN-γ), while no significant effects are ...

Trastuzumab deruxtecan is a HER2-directed antibody and topoisomerase inhibitor conjugate currently marketed under the brand name Enhertu as a second-line therapy for HER2-positive metastatic breast ...

Cesium-137 is a man-made radioactive element sometimes found in contaminated soil, water or food, and has been linked to cancer.

After 36 months, patients treated with high dose AMT-130 saw a 75% slowing of disease progression vs the external control.

HealthDay News — Costco has recalled more than 3000 pounds of its Kirkland Signature Ahi Tuna Wasabi Poke after testing found a risk of listeria contamination.

The COMPASS PWS trial was a 12-week, randomized, double-blind, placebo-controlled, parallel-group study that included 175 patients aged 5 to 30 years with PWS.

Visual outcomes were similar to or slightly better for teenagers aged 17 and 18 years than adults aged 19 to 40 years.

A phase 1/2 study is currently underway to evaluate SAR446268 in participants aged 10 to 50 years with non-congenital myotonic dystrophy type 1.

HealthDay News — In children and adolescents with type 2 diabetes (T2D) or obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) improve glycemic, weight, and cardiometabolic outcomes, ...